Find uplifting stories about heroes, innovations, and solutions
10886 results for "blood cancer treatment"
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
A groundbreaking immunotherapy combination helped 8 in 10 multiple myeloma patients live two years without their cancer getting worse, compared to just 5 in 10 with standard treatment. The global trial involving over 860 patients offers renewed hope for those facing this difficult blood cancer.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
A common, inexpensive blood pressure medication could make certain cancer treatments work better, according to promising new research. Scientists discovered that telmisartan helps the immune system recognize and attack tumors when combined with existing cancer drugs.
Scientists developed a simple blood test that reveals which breast cancer treatments will work before patients waste precious time on ineffective options. The breakthrough could help 2 million people diagnosed globally each year get the right treatment faster.
Thousands of blood cancer patients in England and Wales can now access breakthrough oral treatments that significantly extend survival. The new therapies reduce disease progression by up to 35% compared to standard chemotherapy.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.
A simple blood test is helping doctors track how well cancer treatments work without waiting months for scans. The breakthrough could spare patients from ineffective therapies and catch recurrences earlier than ever before.
Australia has become the first country outside the US to approve a revolutionary therapy for chronic graft-versus-host disease, a serious complication affecting nearly half of blood cancer patients who receive donor stem cell transplants. The treatment was developed from world-first research led by Australian scientists over a decade ago.
Stanford and Mayo Clinic researchers developed a simple blood test that reveals how cells around tumors behave, helping doctors choose the most effective cancer treatments. The breakthrough could transform cancer care from guesswork into precision medicine.
Researchers developed a blood test that could help doctors decide which chemotherapy will work best for young men with testicular cancer. This breakthrough could spare patients from aggressive treatments that won't help them while identifying better options.
Hundreds of patients with rare blood cancers in England can now access two breakthrough treatments that work from home or offer better survival odds. The new approvals bring hope to families facing diseases that once had few options.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
Scientists in Japan discovered that an immune protein older than blood itself could help cancer treatments work better when it's produced directly inside tumors. The breakthrough has already extended survival in mice with treatment-resistant cancer.
Researchers discovered a protein that acts as a natural brake on the most common blood cancer, and restoring it stopped tumors cold in the lab. The finding could help doctors predict which patients need aggressive treatment and may lead to new therapies for those who don't respond to standard care.
Patients battling a rare and stubborn blood cancer just gained a powerful new option after the FDA approved the first drug in its class to treat mantle cell lymphoma. The daily pill offers hope for patients who've exhausted other treatments, with trial results showing responses lasting over a year.
A blood cancer survivor partnered with Indianapolis station WTHR to support Blood Cancer United's mission to cure blood cancer. The collaboration highlights the organization's Light The Night fundraising event.
A new blood test can predict which bladder cancer patients can safely keep their bladder instead of undergoing surgery. In a clinical trial, 80% of patients who avoided immediate surgery remained cancer-free after two years.
Women with advanced breast cancer just gained a powerful new weapon that targets treatment-resistant tumors before they spread further. The FDA approved a drug guided by a simple blood test that detects cancer mutations months before traditional scans can.
A researcher who survived childhood leukemia developed a blood test that detects breast cancer recurrence up to four years before traditional methods. The test is now helping patients in the U.S. catch cancer earlier when treatment works best.
Showing 20 of 10886